Jeremy Wu

H3 Biomedicine Cambridge, MA

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 16 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Table S1 from H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Jaya Julie Joshi,Heather Coffey,Erik Corcoran,Jennifer Tsai,Chia-Ling Huang,Kana Ichikawa,Sudeep Prajapati,Ming-Hong Hao,Suzanna Bailey,Jeremy Wu,Victoria Rimkunas,Craig Karr,Vanitha Subramanian,Pavan Kumar,Crystal MacKenzie,Raelene Hurley,Takashi Satoh,Kun Yu,Eunice Park,Nathalie Rioux,Amy Kim,Weidong G. Lai,Lihua Yu,Ping Zhu,Silvia Buonamici,Nicholas Larsen,Peter Fekkes,John Wang,Markus Warmuth,Dominic J. Reynolds,Peter G. Smith,Anand Selvaraj

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S3andS4 from H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Legends from H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Table S2andS3 from H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S5andS6 from H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S7 from H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S1 from H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S2 from H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S1 from H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

crossref（2023）

Cited0Views0Bibtex

H3B-6527 is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma

Anand Selvaraj,Erik Corcoran,Heather Coffey,Sudeep Prajapati,Ming-Hong Hao,Nicholas Larsen,Jennifer Tsai,Takashi Satoh,Kana Ichikawa,Julie Jaya Joshi,Raelene Hurley,Jeremy Wu,Chia-Ling Huang,Suzanna Bailey,Craig Karr,Pavan Kumar,Victoria Rimkunas,Crystal Mackenzie,Nathalie Rioux,Amy Kim,Sandeep Akare,George Lai,Lihua Yu,Peter Fekkes,John Wang,Markus Warmuth,Peter Smith,Dominic Reynolds

CANCER RESEARCH（2017）

Cited121Views0WOSBibtex

121

Author Statistics

#Papers: 16

#Citation: 220

H-Index: 4

G-Index: 5

Sociability: 4

Diversity: 1

Activity: 0

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn